[1]
capria, saveria et al. 2012. ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 4, 1 (Nov. 2012), e2012072. DOI:https://doi.org/10.4084/mjhid.2012.072.